Posts Tagged: intellectual property
IP Protection for Antibody-based Assets in the Canadian Market and beyond
Together with Noel Courage, MI's Philip Goldbach co-authored an article published in BioTechnology Focus on IP rights and considerations surrounding antibody-based assets. As the article states: Antibodies (immunoglobulins) and other antibody-derived biologics have become a mainstay of the biotechnology industry, both here in Canada and around the world. Novel antibodies are continuously being designed, modified, expressed and purified for a number of uses, including as therapeutics, diagnostics, or research tools. As is the case with other types of life science technologies, intellectual ...
Read more
Miroculus acquires Kapplex to advance diagnostics for complex diseases
Canadian innovation will give patients affordable, non-invasive, accurate test for cancer or infectious diseases; R&D team to remain in Toronto discovery district
TORONTO and SAN FRANCISCO (May 3, 2016) — Miroculus, a San Francisco-based biotechnology company specializing in microRNA-based diagnostics, today announced an agreement to acquire Toronto-based Kapplex Inc. The Canadian company’s proprietary Digital Microfluidic (DMF) platform is built upon the research of Dr. Aaron Wheeler, a world-leader in microfluidics research at the University of Toronto.
This announcement was covered in GenomeWeb and PeHub.
When ...
Read more
Ontario advancing nine medical research projects in cancer, heart disease and sleep apnea to market
Applications for next MSc PoP granting round being accepted until February 25, 2016
TORONTO (January 26, 2016) — Nine Ontario-based medical research projects built on great science with potential for significant economic impact are advancing a step closer to market entry thanks to funding from Ontario Centres of Excellence’s Medical Sciences Proof-of-Principle (MSc PoP) program. The projects range from cancer to heart disease to sleep apnea in children.
Applications for the next MSc PoP granting round are open until March 4, 2016. To ...
Read more
MaRS Innovation sponsoring Angels’ Den competition
Prima IP co-sponsoring the Ryerson University and St. Michael’s Hospital event
When your business demands staying current with the newest inventions springing up across 15 academic members, keeping pace with what’s happening is half the challenge.
That’s part of the reason why MaRS Innovation and Prima IP are sponsoring winners of an Angels’ Den competition involving the Institute for Biomedical Engineering, Science and Technology (iBEST).
iBEST is a partnership between Ryerson University and St. Michael's Hospital that brings together Ryerson's engineering and science strengths ...
Read more
BlueDot, formerly BioDiaspora Inc., secures Series A with Horizons Ventures
Toronto-based commercial arm of BioDiaspora research program tracks global spread of infectious diseases in real-time; fourth MI company to reach Series A
TORONTO (Dec. 2, 2014) — BlueDot, a Toronto-based social benefit corporation founded by Dr. Kamran Khan, an infectious disease physician and scientist, tracks and predicts the global spread of infectious diseases.
Spun off from St. Michael’s Hospital in partnership with MaRS Innovation (and formerly known as BioDiaspora Inc.), BlueDot, has secured a Series A venture capital funding from Horizons Ventures. Funded ...
Read more
Kaypok, MI’s director of intellectual property quoted in the Financial Post
Article focuses on importance of intellectual property protection for small businesses
Dr. Stacey Ivanchuk, MaRS Innovation's director of intellectual property, was quoted in Denise Deveau's article, "Intellectual property protection is a game small businesses can't afford to lose," for the Financial Post on September 26, 2014 regarding the importance of protecting intellectual property for small businesses.
Here's an excerpt:
Stacey Ivanchuk, director of intellectual property for MaRS Innovation in Toronto, says that protecting a startup’s technology is important especially from an investor’s perspective.
“One of ...
Read more
Dr. Rafi Hofstein in Biotechnology Focus: What will it take to regain Canada’s biotechnology leadership?
Biotechnology Focus, a compendium of the Canadian life sciences industry, has published a guest column by MaRS Innovation President & CEO, Dr. Raphael Hofstein.
The article explores the role life sciences assets, financing and talented management--the three Ms--must play in revitalizing Canada's biotechnology sector:
At the close of the 20th century, Canada was perceived as a key contributor to the success of the global biotech voyage.
You know what happened next: the mechanisms to fund early ventures collapsed together with the collapse of the ...
Read more
Flybits selected as a Red Herring Top 100 North America Winner
TORONTO, Canada (May 20, 2014) — Red Herring has selected Flybits as one of its 2014 Top 100 North America award winners. Flybits was recognized for its leading-edge, context-aware computing solutions.
Red Herring Top 100 America recognizes innovation from outstanding entrepreneurs and promising companies. Its “Top 100 North America” award winners were selected from among approximately 3,000 tech start-ups financed each year in the U.S. and Canada. Past winners include companies such as Facebook, Twitter, Google, Yahoo, Skype, Salesforce.com, YouTube, Marin Software, ...
Read more
QSperm: Technology to help couples get pregnant faster
MaRS Innovation and U of T's Innovations & Partnerships Office collaborating with QSperm on intellectual property and business strategy
In vitro fertility treatments can be intensely emotional and medically invasive, not to mention expensive.
But technical developments from a research group at the University of Toronto may soon be able to shorten the journey to pregnancy – and that potential has piqued interest from international investors.
The research group, QSperm, is looking to turn their research into a biotech start-up leveraging an innovative sperm sorting design ...
Read more
Slyce acquires YorkU computer vision technology for retail e-commerce
Deal led by MaRS Innovation and Innovation York to strengthen Slyce’s mobile image recognition application for retail e-commerce
TORONTO, Feb. 4, 2014—Slyce today announced that it has acquired a computer vision technology developed at York University that quickly analyzes and aggregates similar images.
Through the acquisition, Slyce also hired former York PhD student, Dr. Ehsan Fazl-Ersi, to lead the integration of the intellectual property into Slyce’s Visual Search Platform as their new head of Research & Development.
Slyce is a premium provider of visual ...
Read more